TECHNOLOGY SUMMARY
Sphingosine-1 Phosphate (S1P) is an enzyme in humans that has been shown to be upregulated by viruses to help them replicate and spread infection. Our work shows that inhibitors of S1P can protect from infection with Influenza A and other clinically relevant viral infections.
AREA/MATURITY/AWARDS
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Concept
Technology Readiness Level: TRL 3
Vetted Programs/Awards: University of Missouri has been issued US Patent 9,687,487 covering this technology.
SHOWCASE SUMMARY
Organization Type: Academic/Gov Lab
Website: https://missouri.edu/
Showcase Booth #: T63
MARKET KEYWORDS
Market Keywords: Anti-viral, Influenza, Viral